Tag: cancer

COVID mRNA Vaccines Should Be Pulled Off the Market, Oncologist Says

Medical commentator John Campbell, Ph.D., used a recent U.S. Senate hearing on COVID-19 vaccines, cancer and scientific censorship to spotlight concerns he says have been ignored for years — and to argue that the issue demands a public reckoning.

In a series of videos following the June 3 hearing, Campbell described the proceedings as a “massively under-discussed and under-publicized” examination of “possible links between COVID vaccines and cancer and also the active suppression of medical and scientific information.”

“It really couldn’t be more serious for science,” Campbell said in a June 4 video. “Lies are told, lies have been told and things have been ignored. This has resulted in a greatly reduced trust in mainstream media and institutions.”

Campbell devoted a June 7 video to testimony from oncologist Dr. Angus Dalgleish, whose observations of unusual cancer relapses after COVID-19 booster shots led him to question whether vaccine safety was receiving adequate scientific scrutiny.

Last week’s Senate hearing brought those concerns before lawmakers and examined claims that researchers who raise such questions have faced professional and institutional pushback.

The June 3 hearing, “Plausible Mechanisms of COVID-19 Injections Causing Cancer and Attacks on Scientific Publications,” was held by the Senate Permanent Subcommittee on Investigations, chaired by Sen. Ron Johnson (R-Wis.).

Keep reading

Legal Notice Filed to Force EPA to Set Water Standards for Atrazine, a Pesticide Linked to Cancer

Conservation and public health groups filed a formal notice on Thursday, May 28, with Environmental Protection Agency (EPA) Administrator Lee Zeldin to force the agency to develop water-quality standards for atrazine, a pesticide linked to cancer, according to the groups.

According to the notice, atrazine has been found at dangerous levels in thousands of U.S. waterways and in drinking-water supplies. The filing is a required step before the groups can sue the EPA under the Clean Water Act. [1][2]

Atrazine is the second most widely used pesticide in the United States, with tens of millions of pounds applied annually on corn and other crops. The World Health Organization’s International Agency for Research on Cancer in 2025 classified atrazine as “probably carcinogenic to humans,” according to a report from NaturalNews.com. [2] Since 1999, cancer has been the leading cause of premature death in the United States for those under age 85, according to the book “Taking Action, Saving Lives” by Kristin Shrader-Frechette. [3]

The herbicide is banned in more than 60 countries due to links to birth defects, cancers and fertility problems, reported Children’s Health Defense. [4] Atrazine has been shown to disrupt endocrine systems and cause reproductive abnormalities in wildlife, including turning male frogs into hermaphrodites, according to a 2007 report from NaturalNews.com. [5]

The 1972 Clean Water Act regulates discharges into U.S. waterways, but toxic runoff from agriculture continues to pollute, according to a Frontline report cited by Mercola.com. [6] The act requires the EPA to develop water-quality criteria for pollutants; the agency initiated that step in 1999 but never completed it, according to the groups.

Keep reading

Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a Major Cancer Journal

The largest real-world human study to date evaluating ivermectin and mebendazole in cancer patients is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.

Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” represents one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

In this prospective real-world clinical program evaluation, a diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole, with each capsule containing 25 mg ivermectin and 250 mg mebendazole. Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.

At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either no evidence of disease (remission), tumor regression, or cancer stabilization.

Nearly half of all patients (48.4%) reported the strongest positive outcomes, including no evidence of disease (32.8%) or tumor regression (15.6%). An additional 36.1% reported disease stabilization, while only 15.6% reported progression.

Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.

Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.

What makes these findings especially notable is that this was a heterogeneous, real-world cancer population—including patients with prostate, breast, lung, colon, liver, and many other malignancies, many of whom were also undergoing conventional therapies such as chemotherapy, radiation, and surgery.

This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.

Keep reading

‘How do you put a hospice in a burrito stand?’ Watch Congress get stunned by new revelations about astronomical California fraud

The U.S. Congress is being stunned by unnerving revelations about the extent of hospice fraud in California, with alarming testimony indicating phony hospice centers purportedly located in a burrito stand as well as a tire shop.

Sheila Clark, president and CEO of the California Hospice and Palliative Care Association, told lawmakers Tuesday: “How do you put a hospice in a burrito stand in California? How do you put a hospice in a tire store in California? That all had to be vetted through licensure and certification and accreditation.”

“You’d be amazed at how many hospices – the door you can walk up to in California and there is nobody there. There is five months worth of mail that you can see stacked up from CMS and nobody’s there. And that passed a survey. How did that happen?”

The House Ways and Means Committee was so struck by Clark’s disclosure, it shared her testimony on social media, noting: “You heard that right. In Gavin Newsom’s California, a burrito stand masquerading as a hospice care facility was getting accredited and receiving taxpayer dollars.”

While Clark did not name any specific burrito stand, Politics on X explained: “This example illustrates broader federal and state probes into California hospice fraud involving overbilling Medicare, shell companies, identity theft, and improper enrollments, with one recent scheme alone allegedly defrauding Medi-Cal of $267 million.”

Keep reading

Dr. Oz on Insane Fraud: After Stopping Payments to 450 Hospices in CA, NOT ONE Has Asked for Reinstatement of Funds

In March, investigative journalist Nick Shirley released video on uncovering $170 million in fraud in California.

“We uncovered over $170,000,000 in fraud as these fraudsters live in luxury with no consequences,” Nick Shirley said.

“California’s version of Medicaid called ‘Medi-Cal’ has more than doubled since 2022 from $108 billion to a proposed $222 billion in 2026. Their population, however, has not grown exponentially. However, their spending has,” Nick Shirley said.

“There has been a 1,000 percent increase in hospice care in Los Angeles County,” Nick Shirley said. It’s estimated that the fraud in California could be in the hundreds of billions of dollars.”

Nick Shirley visited ‘hospices’ in Los Angeles and ‘daycares’ in San Diego.

In early April, California Attorney General Rob Bonta (D) announced his office had charged 21 suspects in a $267 million hospice fraud ring in Southern California.

A Trump administration Fraud Task Force also conducts raids against healthcare fraudsters across the southern part of the state. Eight people were arrested and charged with over $50 MILLION in fraud.

Keep reading

23 Popular Hair Dyes Test Positive for Carcinogenic Chemicals: Report

An analysis of 23 popular hair color products sold in the United States found that all of them contained at least one carcinogenic chemical.

The tests were conducted on 21 boxed dyes and two temporary hair chalk products from brands including L’Oreal Paris, Dark & Lovely, Madison Reed, Manic Panic, Revlon, and Clairol, consumer advocacy group Consumer Reports (CR) said in a recently published report.

Product samples were sent to an accredited lab, where the items were tested for heavy metals, volatile organic compounds (VOC), and phthalates.

“All 23 samples tested positive for dichloromethane (methylene chloride), a volatile chemical widely used in the U.S. for a variety of products, including paint, adhesives, and pharmaceuticals,” CR said.

The chemical “is classified as a probable carcinogen for humans. Its use is restricted in cosmetics and is generally prohibited except for limited applications, such as in certain hair dye formulations.”

Six product samples contained toluene, a chemical toxic to the central nervous system and a lung irritant.

Keep reading

Four out of five patients reported improvement or stabilisation of their cancer after 6 months of treatment with ivermectin and mebendazole

We have completed the largest real-world human analysis to date evaluating ivermectin and mebendazole in cancer patients – and the results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

The manuscript is now available as a preprint on the Zenodo research repository, operated by the European Organisation for Nuclear Research, while undergoing peer review at leading oncology journals: ‘Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort’.

In this real-world prospective clinical programme evaluation, a diverse population of cancer patients (n=197) were prescribed compounded ivermectin–mebendazole, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.

At approximately six months post-treatment initiation,we observed an 84.4% Clinical Benefit Ratio (“CBR”), with nearly half of cancer patients (48.4%) reporting either no evidence of disease (32.8%) or tumour regression (15.6%).An additional 36.1% reported disease stabilisation. This means more than four out of five patients reported either improvement or stabilisation of their cancer.

These results indicate that the inexpensive and safe off-label applications of these medications could be an important complement in the treatment of cancer.

The groundbreaking analysis was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel – uniting real-world clinical data, frontline medical experience and high-level epidemiologic expertise to deliver urgently needed insights in oncology.

This work was conducted byNicolas Hulscher, MPH (myself); Kelly Victory, MD; James A. Thorp, MD; Drew Pinsky, MD; Alejandro Diaz-Villalobos, MD; Peter Gillooly, MSc; Foster Coulson; Melissa Annazone; Chloe Radesi; Jessica Brooks; Peter A. McCullough, MD, MPH; and Harvey Risch, MD, PhD (Chairman of the President’s Cancer Panel).

The paper can be accessed HERE.

Keep reading

California Attorney General Charges 21 Suspects in $267 Million Hospice Fraud Ring

Democrat officials in California are suddenly interested in prosecuting hospice fraudsters after the Justice Department created a division dedicated to arresting fraudsters.

California Attorney General Rob Bonta (D) on Thursday announced his office charged 21 suspects in a $267 million hospice fraud ring in Southern California.

Five of the 21 suspects have been arrested so far.

“California Attorney General Rob Bonta, together with the California Department of Health Care Services (DHCS), today announced charges filed against 21 suspects and the dismantling of a major hospice fraud scheme that defrauded California of $267 million,” Bonta’s office said.

“Operation Skip Trace resulted in the arrest of five people after ten different locations were searched in Southern California. In addition, two handguns and over $757,000 in cash were seized,” Bonta’s office announced.

“Investigators found that those involved purchased personal identifying information for people living outside of California on the dark web, then enrolled them in Covered California by posing as California residents,” Fox News reported.

“Straw owners” then bought a number of hospice companies and began billing Medi-Cal for services never provided to those stolen identities. The suspects used fake records, nonexistent offices, and fraudulent diagnoses to justify these claims, Bonta said.” – the outlet said.

Keep reading

One of the California Hospices Targeted in Fraud Sting Had a Survival Rate of 97 Percent

One of the hospices targeted in ‘Operation Never Say Die’ today had a survival rate of nearly 100 percent. It’s amazing that these people got away with this for as long as they did.

People check into hospices to die. It’s extremely rare that someone leaves on their feet. At this place, 97 percent of the patients lived. That is a statistical impossibility.

Just imagine how much more of this there is out there.

CBS News reports:

Hospice with 97% survival rate accused of defrauding Medicare for $7.45M

The FBI arrested a married couple Thursday accused of fraudulently billing Medicare for $7.45 million while running a hospice with a survival rate reported to be more than 97% after five years. They were the first in a series of arrests planned Thursday, federal officials told CBS News.

A high survival rate at a hospice provider is one of a series of red flags identified by state auditors for fraud because most people enter hospice care in the final stages of a terminal illness. In past cases of fraud, operators were found to be using false or stolen identities to collect federal reimbursements for palliative care.

The targets of the early morning operation were Gladwin and Amelou Gill, a doctor and psychologist who co-own 626 Hospice, which does business as St. Francis Palliative Care, according to the FBI.

The FBI raid took place in the residential neighborhood of San Dimas, California, as FBI SWAT personnel announced over a loud speaker they have an arrest warrant. CBS News was at the Southern California location when the FBI agents executed the first early morning arrests. Also on the scene was Dr. Mehmet Oz, the Trump-appointed official who oversees the federal Medicare system.

The Justice Department later announced that eight people, including the Gills, had been arrested and federally charged in connection with a health care and hospice fraud investigation.

Keep reading

EPA Failed to Warn Public of Pesticide Cancer Risks Even When Agency Found High Risk

The U.S. Environmental Protection Agency (EPA) has routinely failed to put cancer warnings on pesticide products even when its own assessments have found a high risk of those products causing cancer, according to two new analyses released today by the Center for Food Safety and the Center for Biological Diversity.

The Center for Food Safety analyzed the level of risk the EPA permitted for both currently approved and legacy pesticide active ingredients.

The analysis found that pesticides have been allowed on the market with a cancer risk as high as 1 in every 100 people exposed, a far greater level than the EPA’s benchmark of a 1 in a million chance of developing cancer.

Over the last 40 years, the EPA has approved 200 active ingredients that are “likely” or “possible” carcinogens.

The Center for Biological Diversity analysis examined pesticide product labels for all currently approved pesticide products. The EPA has instituted cancer warnings on only 69 of 4,919 pesticide labels (1.4%) containing an active ingredient that the agency has designated a “likely” human carcinogen.

And the agency has instituted cancer warnings on just 242 of the 22,147 pesticide labels (1.1%) that contain an ingredient the agency has designated as a “possible” human carcinogen.

“It’s bad enough that the EPA approves cancer-causing pesticides,” said Bill Freese, science director at the Center for Food Safety.

“But if the agency is going to allow such chemicals to be freely sold at Home Depot, Wal-Mart and farm-supply stores, the very least the EPA must do is require a clear cancer warning on the label. Warnings save lives by incentivizing users to wear protective equipment that reduces risk.”

“It’s dumbfounding that the EPA has failed to require any cancer warning on thousands of pesticide products sold to the public that the agency itself has linked to cancer,” said Lori Ann Burd, environmental health program director at the Center for Biological Diversity.

“Why should anyone have confidence in the EPA’s ability to keep tabs on the pesticide industry and protect us all from harmful poisons when it won’t even compel companies to put long-term health warnings on pesticides it knows are really dangerous?”

These new analyses come before the April 27 oral arguments in the Supreme Court case Monsanto Company v. John L. Durnell.

Monsanto, since acquired by Bayer, is seeking substantial immunity from future lawsuits brought by Americans who used glyphosate-based products like Roundup and contracted rare cancers that numerous studies have linked to the pesticide.

The case hinges on whether the EPA has sole authority to implement pesticide label warnings.

Keep reading